GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion

• click to rate

  Posted by Two Blokes May 14 - Filed in Stock - 2 views
  
  The pharma giant will pay $1.2 billion up-front for efimosfermin, with deal including potential success-based milestone payments of $800 million.